118 related articles for article (PubMed ID: 36440599)
1. Efficacy of epi-1 modified epirubicin and curcumin encapsulated liposomes targeting-EpCAM in the inhibition of epithelial ovarian cancer cells.
Wang YJ; Tang L; Lu XH; Liu JT; Wang YY; Geng HX; Li XT; An Q
J Liposome Res; 2023 Jun; 33(2):197-213. PubMed ID: 36440599
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity.
Zhou S; Zhang T; Peng B; Luo X; Liu X; Hu L; Liu Y; Di D; Song Y; Deng Y
Int J Pharm; 2017 May; 523(1):203-216. PubMed ID: 28336455
[TBL] [Abstract][Full Text] [Related]
3. Development of R
Liu JJ; Tang W; Fu M; Gong XQ; Kong L; Yao XM; Jing M; Cai FY; Li XT; Ju RJ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1947-1960. PubMed ID: 31079495
[TBL] [Abstract][Full Text] [Related]
4. RPV-modified epirubicin and dioscin co-delivery liposomes suppress non-small cell lung cancer growth by limiting nutrition supply.
Kong L; Cai FY; Yao XM; Jing M; Fu M; Liu JJ; He SY; Zhang L; Liu XZ; Ju RJ; Li XT
Cancer Sci; 2020 Feb; 111(2):621-636. PubMed ID: 31777993
[TBL] [Abstract][Full Text] [Related]
5. Liposomes, modified with PTD(HIV-1) peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer.
Ju RJ; Li XT; Shi JF; Li XY; Sun MG; Zeng F; Zhou J; Liu L; Zhang CX; Zhao WY; Lu WL
Biomaterials; 2014 Aug; 35(26):7610-21. PubMed ID: 24912818
[TBL] [Abstract][Full Text] [Related]
6. Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer.
Song XL; Ju RJ; Xiao Y; Wang X; Liu S; Fu M; Liu JJ; Gu LY; Li XT; Cheng L
Int J Nanomedicine; 2017; 12():7433-7451. PubMed ID: 29066893
[TBL] [Abstract][Full Text] [Related]
7. Epirubicin loaded with propylene glycol liposomes significantly overcomes multidrug resistance in breast cancer.
Zhao YZ; Dai DD; Lu CT; Chen LJ; Lin M; Shen XT; Li XK; Zhang M; Jiang X; Jin RR; Li X; Lv HF; Cai L; Huang PT
Cancer Lett; 2013 Mar; 330(1):74-83. PubMed ID: 23186833
[TBL] [Abstract][Full Text] [Related]
8. Epirubicin-encapsulated long-circulating thermosensitive liposome improves pharmacokinetics and antitumor therapeutic efficacy in animals.
Wu Y; Yang Y; Zhang FC; Wu C; Lü WL; Mei XG
J Liposome Res; 2011 Sep; 21(3):221-8. PubMed ID: 20929434
[TBL] [Abstract][Full Text] [Related]
9. An Application of Tumor-Associated Macrophages as Immunotherapy Targets: Sialic Acid-Modified EPI-Loaded Liposomes Inhibit Breast Cancer Metastasis.
Meng X; Wang M; Zhang K; Sui D; Chen M; Xu Z; Guo T; Liu X; Deng Y; Song Y
AAPS PharmSciTech; 2022 Oct; 23(8):285. PubMed ID: 36258152
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of in vitro antitumour activity of epirubicin in HER2+ breast cancer cells using immunoliposome formulation.
Khaleseh F; Hemmati Azandaryani A; Fathian Kolahkaj F; Khazaei M; Derakhshandeh K
IET Nanobiotechnol; 2021 May; 15(3):257-265. PubMed ID: 34694666
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumor efficacy using epirubicin and schisandrin B co-delivery liposomes modified with PFV via inhibiting tumor metastasis.
Jing M; Bi XJ; Yao XM; Cai F; Liu JJ; Fu M; Kong L; Liu XZ; Zhang L; He SY; Jia LQ; Li XT
Drug Dev Ind Pharm; 2020 Apr; 46(4):621-634. PubMed ID: 32162988
[TBL] [Abstract][Full Text] [Related]
12. Polysialic acid-modifying liposomes for efficient delivery of epirubicin, in-vitro characterization and in-vivo evaluation.
Zhang T; Zhou S; Hu L; Peng B; Liu Y; Luo X; Song Y; Liu X; Deng Y
Int J Pharm; 2016 Dec; 515(1-2):449-459. PubMed ID: 27789365
[TBL] [Abstract][Full Text] [Related]
13. Sialic acid conjugate-modified liposomes enable tumor homing of epirubicin via neutrophil/monocyte infiltration for tumor therapy.
Ding J; Sui D; Liu M; Su Y; Wang Y; Liu M; Luo X; Liu X; Deng Y; Song Y
Acta Biomater; 2021 Oct; 134():702-715. PubMed ID: 34339869
[TBL] [Abstract][Full Text] [Related]
14. Polysialic acid-polyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency.
Zhang T; Zhou S; Hu L; Peng B; Liu Y; Luo X; Liu X; Song Y; Deng Y
Drug Deliv Transl Res; 2018 Jun; 8(3):602-616. PubMed ID: 29536348
[TBL] [Abstract][Full Text] [Related]
15. Vitamin C-driven epirubicin loading into liposomes.
Lipka D; Gubernator J; Filipczak N; Barnert S; Süss R; Legut M; Kozubek A
Int J Nanomedicine; 2013; 8():3573-85. PubMed ID: 24101870
[TBL] [Abstract][Full Text] [Related]
16. Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo.
Lo YL; Liu Y; Tsai JC
Biomed Pharmacother; 2013 May; 67(4):261-7. PubMed ID: 23540284
[TBL] [Abstract][Full Text] [Related]
17. Accelerated drug release and clearance of PEGylated epirubicin liposomes following repeated injections: a new challenge for sequential low-dose chemotherapy.
Yang Q; Ma Y; Zhao Y; She Z; Wang L; Li J; Wang C; Deng Y
Int J Nanomedicine; 2013; 8():1257-68. PubMed ID: 23576868
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylated liposomal nanoparticle for breast cancer.
Tang H; Chen J; Wang L; Li Q; Yang Y; Lv Z; Bao H; Li Y; Luan X; Li Y; Ren Z; Zhou X; Cong D; Liu Z; Jia J; Chen H; Zhao W; Meng Q; Sun F; Pei J
Int J Pharm; 2020 Jan; 573():118806. PubMed ID: 31678519
[TBL] [Abstract][Full Text] [Related]
19. Targeting Epirubicin Plus Quinacrine Liposomes Modified with DSPE-PEG2000-C(RGDfK) Conjugate for Eliminating Invasive Breast Cancer.
Sun MG; Shi JF; Li XY; Zhao Y; Ju RJ; Mu LM; Yan Y; Li XT; Zeng F; Lu WL
J Biomed Nanotechnol; 2015 Aug; 11(8):1339-53. PubMed ID: 26295137
[TBL] [Abstract][Full Text] [Related]
20. Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance.
Yu M; Han S; Kou Z; Dai J; Liu J; Wei C; Li Y; Jiang L; Sun Y
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):323-332. PubMed ID: 28393563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
